Clinical Trials at The Male / FemaleHealth and Research Center
During the past decade, The Male / FemaleHealth and Research Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery
Doxorubicin Hydrochloride, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer
Capecitabine and Lapatinib Ditosylate With or Without Cixutumumab in Treating Patients With Previously Treated HER2-Positive Stage IIIB-IV Breast Cancer
Sunitinib Malate as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemotherapy
2008-06-15
2015-05-28
Completed
210
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at The Male / FemaleHealth and Research Center
According to Clinical.Site data, the most researched conditions in "The Male / FemaleHealth and Research Center" are
"Benign Prostatic Hypertrophy" (2 trials). Many other conditions were trialed in "The Male / FemaleHealth and Research Center" in a lesser frequency.
Clinical Trials Intervention Types at The Male / FemaleHealth and Research Center
Most popular intervention types in "The Male / FemaleHealth and Research Center" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Cetrorelix 78 mg + 52 mg" (1 trials), "Cetrorelix 78 mg + 78 mg" (1 trials), "Cetrorelix Pamoate" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.
Clinical Trials Genders at The Male / FemaleHealth and Research Center
The vast majority of trials in "The Male / FemaleHealth and Research Center" are
2 trials for "Male" genders.
Clinical Trials Status at The Male / FemaleHealth and Research Center
Currently, there are NaN active trials in "The Male / FemaleHealth and Research Center".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in The Male / FemaleHealth and Research Center,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in The Male / FemaleHealth and Research Center, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".